Purdue Pharma is close to reaching an agreement to plead guilty to charges related to worsening the opioid epidemic in the U.S., according to an exclusive report from Reuters on Wednesday.
A plea deal between Purdue’s lawyers and federal prosecutors is expected to be announced within the next two weeks, according to six sources close to the situation. Along with criminal charges, negotiations for a civil claim are also ongoing for alleged unlawful conduct in Purdue’s handling of prescription painkillers.
The pharmaceutical company could face penalties exceeding $8 billion. Purdue is accused of engaging in illegal kickback programs that paid doctors and pharmacies to prescribe medically unnecessary opioids. The Sackler family, who control Purdue, are in discussions to pay $225 million for false claims about prescription painkillers. Current settlement discussions will not absolve the Sacklers from criminal liability they may face in the future.
Federal prosecutors launched a federal probe